The secretion of PAPP-A, ADAM12, and PP13 correlates with the size of the placenta for the first month of pregnancy

Placenta

Volumn 32, Issue 12, 2011, Pages 999-1003

  Sahraravand, M ^a   Jarvela I Y ^a   Laitinen, P ^a   Tekay, A H ^a   Ryynanen M ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

1st trimester; ADAM12; Gestational sac; PAPP A; Placenta; PP13; Three dimensional ultrasonography

Indexed keywords

A DISINTEGRIN AND METALLOPROTEASE PROTEIN 12; BIOLOGICAL MARKER; PLACENTAL PROTEIN 13; PREGNANCY ASSOCIATED PROTEIN A; UNCLASSIFIED DRUG; ADAM 12 PROTEIN; ADAM PROTEIN; GALECTIN; LGALS13 PROTEIN, HUMAN; MEMBRANE PROTEIN; PLACENTA PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; ECHOGRAPHY; FEMALE; FOLLOW UP; GESTATIONAL AGE; GESTATIONAL SAC; HUMAN; HUMAN TISSUE; LONGITUDINAL STUDY; NIDATION; OBSERVATIONAL STUDY; PLACENTA; PLACENTA DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; THREE DIMENSIONAL IMAGING; FIRST TRIMESTER PREGNANCY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; SECRETION;

ADAM PROTEINS; ADULT; FEMALE; GALECTINS; HUMANS; LONGITUDINAL STUDIES; MEMBRANE PROTEINS; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;

EID: 84857361635     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2011.10.005     Document Type: Article

References (29)

1. Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update 2006;12:747-55. (Pubitemid 44605512)
2. Csapo AI, Pulkkinen M. Indispensability of the human corpus luteum in the maintenance of early pregnancy. luteectomy evidence. Obstet Gynecol Surv 1978;33:69-81. (Pubitemid 8267883)
3. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357:53-6. (Pubitemid 32056505)
4. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049-59. (Pubitemid 16004866)
5. Cowans NJ, Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 2007;27:264-71. (Pubitemid 46450586)
6. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early-pregnancy origins of low birth weight. Nature 2002;417:916. (Pubitemid 34716861)
7. Chafetz I, Kuhnreich I, Sammar M, Tal Y, Gibor Y, Meiri H, et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2007;197:35.e1-7.
8. Wortelboer EJ, Koster MP, Cuckle HS, Stoutenbeek PH, Schielen PC, Visser GH. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. BJOG 2010;117:1384-9.
9. Gilpin BJ, Loechel F, Mattei MG, Engvall E, Albrechtsen R, Wewer UM. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem 1998;273:157-66. (Pubitemid 28042189)
10. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U. S. A 1999;96:3149-53. (Pubitemid 29148859)
11. Shi Z, Xu W, Loechel F, Wewer UM, Murphy LJ. ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3. J Biol Chem 2000;275:18574-80. (Pubitemid 30414820)
12. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 2003;110:281-6. (Pubitemid 36298912)
13. Järvelä IY, Niinimäki M, Martikainen H, Ruokonen A, Tapanainen JS. Ovarian response to the human chorionic gonadotrophin stimulation test in normal ovulatory women: the impact of regressing corpus luteum. Fertil Steril 2007;87:1122-30. (Pubitemid 46659947)
14. Järvelä IY, Sladkevicius P, Tekay AH, Campbell S, Nargund G. Intraobserver and interobserver variability of ovarian volume, gray-scale and color flow indices obtained using transvaginal three-dimensional power doppler ultrasonography. Ultrasound Obstet Gynecol 2003;21:277-82. (Pubitemid 36390715)
15. Järvelä IY, Ruokonen A, Tekay A. Effect of rising hCG levels on the human corpus luteum during early pregnancy. Hum Reprod 2008;23:2775-81.
16. Bischof P, Du Berg S, Herrmann W, Sizonenko PC. Pregnancy-associated plasma protein-A (PAPP-A) and hCG in early pregnancy. Br J Obstet Gynaecol 1981;88:973-5. (Pubitemid 11028064)
17. Sinosich MJ, Teisner B, Folkersen J, Saunders DM, Grudzinskas JG. Radioimmunoassay for pregnancy-associated plasma protein A. Clin Chem 1982;28:50-3. (Pubitemid 12209750)
18. Loechel F, Fox JW, Murphy G, Albrechtsen R, Wewer UM. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 2000;278:511-5.
19. Kveiborg M, Albrechtsen R, Couchman JR, Wewer UM. Cellular roles of ADAM12 in health and disease. Int J Biochem Cell Biol 2008;40:1685-702.
20. Burger O, Pick E, Zwickel J, Klayman M, Meiri H, Slotky R, et al. Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 2004;25:608-22. (Pubitemid 38950314)
21. Than NG, Pick E, Bellyei S, Szigeti A, Burger O, Berente Z, et al. Functional analyses of placental protein 13/galectin-13. Eur J Biochem 2004;271:1065-78. (Pubitemid 38373040)
22. Wortelboer EJ, Koster MP, Kuc S, Eijkemans MJ, Bilardo CM, Schielen PC, et al. Longitudinal trends in feto-placental biochemical markers, uterine artery doppler flow velocities and maternal blood pressure during the first-trimester of pregnancy. Ultrasound Obstet Gynecol; 2011.
23. Valinen Y, Laitinen P, Ranta J, Ignatius J, Jarvela I, Ryynanen M. Effect of a new marker, ADAM12, on down risk figures in first trimester screening. J Matern Fetal Neonatal Med 2009;22:602-7.
24. Koster MP, Wortelboer EJ, Stoutenbeek P, Visser GH, Schielen PC. Modeling the down syndrome screening performance using first trimester serum markers. Ultrasound Obstet Gynecol; 2010.
25. Valinen Y, Peuhkurinen S, Jarvela IY, Laitinen P, Ryynanen M. Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester. Gynecol Obstet Invest. 2010;70:60-3.
26. Csapo AI, Pulkkinen MO, Wiest WG. Effects of luteectomy and progesterone replacement therapy in early pregnant patients. Am J Obstet Gynecol 1973;115:759-65.
27. Tulchinsky D, Hobel CJ, Yeager E, Marshall JR. Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am J Obstet Gynecol 1972;112:1095-100.
28. Tulchinsky D, Hobel CJ. Plasma human chorionic gonadotropin, estrone, estradiol, estriol, progesterone, and 17 alpha-hydroxyprogesterone in human pregnancy. 3. Early normal pregnancy. Am J Obstet Gynecol 1973;117:884-93.
29. Hay DL. Placental histology and the production of human choriogonadotrophin and its subunits in pregnancy. Br J Obstet Gynaecol 1988;95:1268-75. (Pubitemid 19032908)